Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.79 USD | -1.19% | +3.85% | +18.57% |
May. 13 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.57% | 11.16M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+44.98% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Cerecor : Cantor Fitzgerald Initiates Coverage on Cerecor With Overweight Rating, $7 Price Target